All News about Merck & CoVia Benzinga
Expert Ratings for Merck & Co
February 22, 2023
Via Benzinga
Via Benzinga
Merck Provides Update on Phase 3 Trials KEYNOTE-641 and KEYNOTE-789
February 28, 2023
From Merck & Co., Inc.
Via Business Wire
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
February 26, 2023
Via Benzinga
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|